Physician profile
Amanda Jo Dropic
NPI 1073720090
$993.35
in general payments reported to CMS, 2019-2025
18 companies · $67.13 in 2025
The $67.13 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $52.41 · 2021: $88.38 · 2022: $191 · 2023: $242 · 2024: $217 · 2025: $67.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $254.82 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $120.98 | 2021-2024 | Azstarys |
| Tris Pharma INC | $87.26 | 2019-2025 | Dyanavel Xr |
| Sanofi Pasteur INC. | $73.71 | 2021-2024 | |
| Pfizer INC. | $53.26 | 2019-2024 | |
| Cranial Technologies, INC | $53.15 | 2022-2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $50.15 | 2020-2023 | Jornay Pm |
| Sobi, INC | $46.12 | 2019-2023 | |
| Glaxosmithkline, LLC. | $38.68 | 2023-2024 | Bexsero |
| Seqirus USA INC | $36.19 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Merck Sharp & Dohme LLC | $31.83 | 2022-2023 | Vaxneuvance, M-M-R II, Varivax |
| Neos Therapeutics, LP | $28.56 | 2023-2025 | Cotempla Xr-Odt |
| Rhodes Pharmaceuticals L.P. | $24.10 | 2019 | |
| Alk-Abello, INC | $22.68 | 2023 | Grastek, Ragwitek, Odactra |
| Ars Pharmaceuticals Operations, INC. | $22.20 | 2025 | Neffy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $19.87 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.50 | 2020 | |
| Shire North American Group INC | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Dropic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.